Treatment of AMs with ARDS BAL reduced Rac1 mRNA expression compared to VC treatment (Figure 1C, median of differences 0.48, p = 0.016), which supports our finding that ARDS BAL inhibits AM efferocytosis. This evidence concerns the gene RAC1 and acute respiratory distress syndrome.